Investigative Clinical Research is categorized under Medical Labs in Rancho Cucamonga, CA and active since 1997.
Investigative Clinical Research was established in 1997, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Medical Labs business, which does work in the B2C market, and is classified as a Medical Labs, under code number 621511 by the NAICS.
If you are seeking more information, feel free to contact Jessie Weitman at the company’s single location by writing to 7974 Haven Avenue # 290, Rancho Cucamonga, California CA 91730 or by phoning (512) 589-3454. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Investigative Clinical Research |
| Contact Person: | Jessie Weitman |
| Address: | 7974 Haven Avenue # 290, Rancho Cucamonga, California 91730 |
| Phone Number: | (512) 589-3454 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 1997 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Medical Labs |
| SIC Code: | 8071 |
| NAICS Code: | 621511 |
| Share This Business: |
Investigative Clinical Research was started in 1997 to provide professional Medical Labs under the SIC code 8071 and NAICS code 621511. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Jessie Weitman for inquiries that concern Investigative Clinical Research by calling the company number (512) 589-3454, as your correspondence is most welcome. Additionally, the physical location of the single location of Investigative Clinical Research can be found at the coordinates as well as the street address 7974 Haven Avenue # 290 in Rancho Cucamonga, California 91730.
For its online presence, you may visit Investigative Clinical Research’s website at and engage with its social media outlets through on Twitter and on Facebook.